CIS
DXCM icon

Capital International Sarl’s DexCom DXCM Stock Holding History

Capital International Sarl’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,107
Closed -$2.71M – 224
2023
Q2 		$2.71M Buy
21,107
+2,545
+14% +$308K 0.12% 155
2023
Q1 		$2.16M Buy
18,562
+2,081
+13% +$233K 0.11% 173
2022
Q4 		$1.87M Buy
16,481
+2,730
+20% +$300K 0.13% 162
2022
Q3 		$1.11M Buy
13,751
+623
+5% +$52.8K 0.09% 185
2022
Q2 		$978K Buy
13,128
+3,036
+30% +$277K 0.08% 188
2022
Q1 		$1.29M Buy
10,092
+7,996
+381% +$875K 0.06% 219
2021
Q4 		$281K Buy
+2,096
New +$301K 0.01% 251

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Sarl's DXCM Position: Q3 2023 in Review

Capital International Sarl sold out of DexCom (DXCM) in Q3 2023, closing a stake of 21,107 shares — an estimated $2.71M sold.

Capital International Sarl first reported a position in DXCM in Q4 2021 and held it in 7 quarters. The position peaked at $2.71M in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Capital International Sarl reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Capital International Sarl sold 21,107 DexCom shares in Q3 2023, an estimated $2.71M.
  • Capital International Sarl first reported a position in DexCom in Q4 2021 and held it in 7 quarters.
  • Capital International Sarl's DexCom position peaked at $2.71M in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Capital International Sarl's 13F filing for Q3 2023, filed 13 Nov 2023.